Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus

Ophthalmology

Prevalence

25.0 / 100K

Incidence

1.5 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus?

There are 1 clinical trial targeting Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus tracked by BioSniper.

What is the prevalence of Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus?

The estimated prevalence of Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus is approximately 25.0 per 100,000 population.

Deep-dive into Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus — Drugs in Development & Clinical Trials | BioSniper